Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Publishing timestamp: 2024-03-16 07:00:01
Summary
Wegovy, a weight loss drug, is now approved in the U.S. for heart health, but some health plans and employers are hesitant to cover it due to its high price tag. The drug's approval could lead to wider insurance coverage in the future, but there are concerns about long-term use and costs. Insurers are facing difficult decisions on whether to cover weight loss treatments, and some are already implementing cost control measures.
Sentiment: MIXED
Tickers: CVS, NVO, NOVO.B-DK, LLY, CI,
Keywords: insurance industry, business news, renter's insurance, health care industry, biotechnology, weight management, cvs health corp, novo nordisk a/s, business, biotech and pharmaceuticals, breaking news, labor economy, eli lilly and co, united states, cigna corp, social issues, pharmaceuticals,
Source: https://www.cnbc.com/2024/03/16/wegovy-heart-health-insurance-coverage.html